第1章 摘要整理

第2章 調查範圍

第3章 產品簡介

第4章 市場調查手法

第5章 疾病概要

第6章 開發平台分析

第7章 簡介

第8章 市場形勢

第9章 市場區隔:胰島素類別

第10章 市場區隔:疾病類別

第11章 地區部門

第12章 推動市場成長要素

第13章 成長推動因素的影響

第14章 市場課題

第15章 推動因素與課題的影響

第16章 市場趨勢

第17章 業者情勢

競爭模式

市場佔有率分析

其他卓越供應商

第18章 主要供應商分析

Lilly

Novo Nordisk

Sanofi

第19章 附錄

簡稱清單

第20章 關於Technavio

圖表

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Product Code: IRTNTR6990

About diabetes

Insulin is a hormone produced by beta cells of the pancreas that plays a key role in the regulation of blood glucose levels. It controls the body systems and regulates the uptake of amino acids by body cells. It helps cells absorb glucose from the blood. In diabetics, cells stop responding to the insulin produced. As a result, glucose in the blood cannot be absorbed by the cells of the body. This condition damages body tissues over the period of time and causes disabling and life-threatening health complications such as diabetic nephropathy and diabetic retinopathy. In type 1 diabetes, the body does not produces sufficient insulin to regulate blood glucose level. Individuals with this type of diabetes need to take insulin daily. Patients with type 2 diabetes also need doses of insulin coupled with medication. Different types of insulin such as human insulin and insulin analogs are available as insulin replacement therapy.

Technavio's analysts forecast the global human insulin market to grow at a CAGR of 10.29% over the period 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the global human insulin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of diabetes.

Technavio's report, Global Human Insulin Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market.

Key vendors

Eli Lilly

Novo Nordisk

Sanofi

Other Prominent Vendors

Biocon

Biodel

Biogenomics

Boehringer Ingelheim

Bristol-Myers Squibb

Diamyd Medical

Diasome Pharmaceuticals

DiaVacs

Pfizer

Generex Biotechnology

Lexicon Pharmaceuticals

Macrogenics

Merck

Oramed Pharmaceuticals

Osiris Therapeutics

Thermalin Diabetes

Tolerion

Wockhardt

XOMA Corporation

Market driver

Increase in prevalence of diabetes

For a full, detailed list, view our report

Market challenge

Stringent regulatory environment

For a full, detailed list, view our report

Market trend

Increasing R&D for novel mechanisms

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2019 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?